| Kenneth G Borie, MD | |
|
44 S Main St, Randolph, VT 05060-1381 | |
| (802) 728-2445 | |
| (802) 728-2394 |
| Full Name | Kenneth G Borie |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 51 Years |
| Location | 44 S Main St, Randolph, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144233206 | NPI | - | NPPES |
| 0005104 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 0320000268 (Vermont) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayada Home Health Care | Williston, VT | Home health agency |
| Gifford Medical Center | Randolph, VT | Hospital |
| Mary Hitchcock Memorial Hospital | Lebanon, NH | Hospital |
| Central Vermont Medical Center | Barre, VT | Hospital |
| Mayo Healthcare Inc. | Northfield, VT | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gifford Health Care Inc | 2668624982 | 33 |
News Archive
Researchers from King's College London have shown that whole body magnetic resonance imaging (WBMRI) not only detects more myeloma-defining disease than positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (FDG) but that it also allows critical treatment to be initiated earlier.
Synergetics USA, Inc., a medical device company that designs, manufactures, and markets innovative products for ophthalmic and neurosurgical applications, has introduced the CMC® V, the next generation of the Codman® Malis® electrosurgical generator. Codman & Shurtleff, Inc. is the exclusive distributor of the CMC® V. CMC and Codman are registered trademarks of Johnson & Johnson Corporation.
Professor James Lorens and his team at the University of Bergen's Department of Biomedicine are using nanotechnology to study how to make cells form new blood vessels, both within the patient's body and in the laboratory. In the next phase the team will use this knowledge to investigate the molecular mechanisms that govern the progression of cancer.
The Biden administration — keeping a campaign promise — announced it would back a temporary waiver of patent protections for the covid-19 vaccines, arousing the ire of the drug industry.
The EU Joint Programme - Neurodegenerative Disease Research (JPND) is inviting calls for proposals from research teams across Europe to increase understanding of the factors that put people at risk of developing neurodegenerative diseases (ND) such as Alzheimer's and also to evaluate health and social care strategies for people living with these debilitating illnesses.
› Verified 2 days ago
| Entity Name | Gifford Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942329446 PECOS PAC ID: 4880683663 Enrollment ID: O20040507000460 |
News Archive
Researchers from King's College London have shown that whole body magnetic resonance imaging (WBMRI) not only detects more myeloma-defining disease than positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (FDG) but that it also allows critical treatment to be initiated earlier.
Synergetics USA, Inc., a medical device company that designs, manufactures, and markets innovative products for ophthalmic and neurosurgical applications, has introduced the CMC® V, the next generation of the Codman® Malis® electrosurgical generator. Codman & Shurtleff, Inc. is the exclusive distributor of the CMC® V. CMC and Codman are registered trademarks of Johnson & Johnson Corporation.
Professor James Lorens and his team at the University of Bergen's Department of Biomedicine are using nanotechnology to study how to make cells form new blood vessels, both within the patient's body and in the laboratory. In the next phase the team will use this knowledge to investigate the molecular mechanisms that govern the progression of cancer.
The Biden administration — keeping a campaign promise — announced it would back a temporary waiver of patent protections for the covid-19 vaccines, arousing the ire of the drug industry.
The EU Joint Programme - Neurodegenerative Disease Research (JPND) is inviting calls for proposals from research teams across Europe to increase understanding of the factors that put people at risk of developing neurodegenerative diseases (ND) such as Alzheimer's and also to evaluate health and social care strategies for people living with these debilitating illnesses.
› Verified 2 days ago
| Entity Name | Gifford Health Care Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013269430 PECOS PAC ID: 2668624982 Enrollment ID: O20121213000467 |
News Archive
Researchers from King's College London have shown that whole body magnetic resonance imaging (WBMRI) not only detects more myeloma-defining disease than positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (FDG) but that it also allows critical treatment to be initiated earlier.
Synergetics USA, Inc., a medical device company that designs, manufactures, and markets innovative products for ophthalmic and neurosurgical applications, has introduced the CMC® V, the next generation of the Codman® Malis® electrosurgical generator. Codman & Shurtleff, Inc. is the exclusive distributor of the CMC® V. CMC and Codman are registered trademarks of Johnson & Johnson Corporation.
Professor James Lorens and his team at the University of Bergen's Department of Biomedicine are using nanotechnology to study how to make cells form new blood vessels, both within the patient's body and in the laboratory. In the next phase the team will use this knowledge to investigate the molecular mechanisms that govern the progression of cancer.
The Biden administration — keeping a campaign promise — announced it would back a temporary waiver of patent protections for the covid-19 vaccines, arousing the ire of the drug industry.
The EU Joint Programme - Neurodegenerative Disease Research (JPND) is inviting calls for proposals from research teams across Europe to increase understanding of the factors that put people at risk of developing neurodegenerative diseases (ND) such as Alzheimer's and also to evaluate health and social care strategies for people living with these debilitating illnesses.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kenneth G Borie, MD Po Box 2000, 44 South Main Street, Randolph, VT 05060-2000 Ph: (802) 728-2445 | Kenneth G Borie, MD 44 S Main St, Randolph, VT 05060-1381 Ph: (802) 728-2445 |
News Archive
Researchers from King's College London have shown that whole body magnetic resonance imaging (WBMRI) not only detects more myeloma-defining disease than positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose (FDG) but that it also allows critical treatment to be initiated earlier.
Synergetics USA, Inc., a medical device company that designs, manufactures, and markets innovative products for ophthalmic and neurosurgical applications, has introduced the CMC® V, the next generation of the Codman® Malis® electrosurgical generator. Codman & Shurtleff, Inc. is the exclusive distributor of the CMC® V. CMC and Codman are registered trademarks of Johnson & Johnson Corporation.
Professor James Lorens and his team at the University of Bergen's Department of Biomedicine are using nanotechnology to study how to make cells form new blood vessels, both within the patient's body and in the laboratory. In the next phase the team will use this knowledge to investigate the molecular mechanisms that govern the progression of cancer.
The Biden administration — keeping a campaign promise — announced it would back a temporary waiver of patent protections for the covid-19 vaccines, arousing the ire of the drug industry.
The EU Joint Programme - Neurodegenerative Disease Research (JPND) is inviting calls for proposals from research teams across Europe to increase understanding of the factors that put people at risk of developing neurodegenerative diseases (ND) such as Alzheimer's and also to evaluate health and social care strategies for people living with these debilitating illnesses.
› Verified 2 days ago
Brian Sargent, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-685-0030 Fax: 802-685-4329 | |
Robert C Kiess, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-763-8000 Fax: 802-728-2394 | |
Shelly L Gasow, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-234-9913 Fax: 802-728-2394 | |
Mark G. Seymour, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-234-9913 Fax: 802-728-2394 | |
Marcus H Coxon, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-728-2445 Fax: 802-728-2613 | |
Emilija O Florance, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 44 S Main St, Randolph, VT 05060 Phone: 802-728-7000 |